To the editor: Waldenstrom’s macroglobulinemia (WM) is a rare indolent B-cell lymphoma. Approximately 1000-1500 new cases of WM are diagnosed every year in the United States.[1][1] Although previous studies suggested prolonged survival in WM patients, it is unclear whether there have been
No takes yet. Share an insight, caveat, or question.
Castillo et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: